GSK Launches $2.5 Billion Cost-Cutting Plan to Boost Drug Pipeline
Macro·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
GSK has announced a $2.5 billion savings initiative aimed at enhancing its drug pipeline as it prepares for an impending patent cliff. The company has not yet disclosed the specifics regarding potential job cuts that may accompany this restructuring effort.
This strategic move comes in light of GSK's recent earnings report, where the company is taking proactive measures to ensure its future growth and sustainability in the competitive pharmaceutical landscape.
GSK
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“GSK launches $2.5 billion savings drive to boost drug pipeline”
Yahoo Finance — GSK launches $2.5 billion savings drive to boost drug pipeline“<figure><div><img”
biopharma dive — GSK prepares for patent cliff with $2.5B cost-cutting plan